DENVER/Aug. 3, 2023 – A newly funded study will evaluate the potential of a cancer drug to control tumor growth and improve outcomes for dogs with histiocytic sarcoma, an aggressive and typically ...
Presentation of congenital soft-tissue sarcomas: A single institution experience. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text ...
Histiocytic disorders are a group of disorders arising from an over-production of histiocytic white blood cells called histiocytes. ‘Histiocytosis’, meaning ‘tissue cell’, is a general concept for ...
Prioritization of Therapy Options for a Patient With High Tumor Mutation Burden and Microsatellite Instability but No Clinical Benefit From Immunotherapy ...
OXFORD, England--(BUSINESS WIRE)--Oxford BioDynamics Plc (AIM: OBD, the “Company”), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform, announces ...
Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis marked by the infiltration of lipid-laden histiocytes into multiple organ systems. Clinically, patients often present with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results